We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Correction to affiliation details of a nanocarrier study for tumor-targeted delivery of siRNA, highlighting key findings in pharmaceutics.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: